Compare CYCN & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYCN | EDTK |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 14.3M |
| IPO Year | 2019 | 2019 |
| Metric | CYCN | EDTK |
|---|---|---|
| Price | $23.52 | $1.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 114.2K | 6.1K |
| Earning Date | 05-08-2026 | 01-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.26 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,074,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $1.03 | $0.80 |
| 52 Week High | $8.48 | $1.18 |
| Indicator | CYCN | EDTK |
|---|---|---|
| Relative Strength Index (RSI) | 41.06 | 64.49 |
| Support Level | $3.04 | $0.91 |
| Resistance Level | $3.42 | $1.02 |
| Average True Range (ATR) | 0.49 | 0.03 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 23.67 | 93.52 |
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.